SCHEMBL4024935

SCHEMBL4024935

Cn1c(-c2sccc2NCC=Cc2ccccc2)nc(C(=O)O)c(O)c1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC1 P07992 1/20 0.50
FEN1 P39748 1/20 0.50
ERCC4 Q92889 1/20 0.50
HDAC1 Q13547 3/20 0.33
HDAC6 Q9UBN7 3/20 0.33
HDAC8 Q9BY41 2/20 0.33
MAPK1 P28482 1/20 0.33
DHFR P00374 1/20 0.33
HTT P42858 1/20 0.33
MAPK8 P45983 1/20 0.33
MAPK10 P53779 1/20 0.33
P2RX3 P56373 1/20 0.32
HSD17B10 Q99714 1/20 0.32
TSHR P16473 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
MAPT P10636 2/20 0.32
GAA P10253 1/20 0.32
KDM4E B2RXH2 1/20 0.32
LMNA P02545 1/20 0.32
ESR1 P03372 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4024930 1.00 ERCC1 (0.50) ERCC1FEN1ERCC4HDAC1HDAC6
SCHEMBL4034538 0.86 ERCC1 (0.35) ERCC1FEN1ERCC4HDAC1HDAC6
SCHEMBL4028792 0.81 ERCC1 (0.57) ERCC1FEN1ERCC4MAPK1P2RX3
SCHEMBL4034573 0.81 ERCC1 (0.57) ERCC1FEN1ERCC4MAPK1P2RX3
SCHEMBL4028450 0.80 FEN1 (0.51) ERCC1FEN1ERCC4HDAC1HDAC6
SCHEMBL4027815 0.80 DHFR (0.31) DHFR
SCHEMBL4027808 0.80 DHFR (0.31) DHFR
SCHEMBL4027570 0.79 ERCC1 (0.55) ERCC1FEN1ERCC4MAPK1HTT
SCHEMBL4025695 0.79 ERCC1 (0.49) ERCC1FEN1ERCC4MAPK8MAPK10
SCHEMBL4028016 0.78 FEN1 (0.58) ERCC1FEN1ERCC4MAPK8MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1470113-B1 PYRIMIDINONE VIRAL POLYMERASE INHIBITORS ANGELETTI P IST RICHERCHE BIO (IT) 2009-01-07 EP claimed
US-20050130997-A1 Pyrimidinone viral polymerase inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2005-06-16 US claimed
EP-1470113-B1 PYRIMIDINONE VIRAL POLYMERASE INHIBITORS ANGELETTI P IST RICHERCHE BIO (IT) 2009-01-07 EP disclosed
US-20050130997-A1 Pyrimidinone viral polymerase inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2005-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050130997-A1 Pyrimidinone viral polymerase inhibitors POLR2A, POLR1E, POLR2E ERCC1 3181/4885FEN1 343/4885ERCC4 1663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.